Activities

Work package 4: Phase Ia/b clinical trial in The Netherlands and Burkina Faso

Led by Leiden University Medical Center, The Netherlands

The main objectives of this work package are to:

  • To evaluate the safety of three doses of increasing strength formulation of Shigella vaccine given at three time points in healthy Dutch and Burkinabe adults.

  • To assess the immunogenicity of three doses of increasing strength formulation of Shigella vaccine given at three time points in healthy Dutch and Burkinabe adults.

Partner

Join European Vaccine Initiative mailing list for updates on projects, training and funding opportunities

  • LinkedIn - White Circle
  • Twitter - White Circle

This project is part of the EDCTP2 Programme supported by the European Union (RIA2018V-2308)